How to Get Strimvelis Gene Therapy Covered by Blue Cross Blue Shield in Ohio: Complete Appeal Guide with Forms and Timelines
Answer Box: Getting Strimvelis Covered in Ohio
Strimvelis (ADA-SCID gene therapy) requires prior authorization from Blue Cross Blue Shield in Ohio, with appeals following a structured timeline: internal review (30 days), second-level appeal if needed, then external review through Ohio's Independent Review Organization (180-day deadline from final denial)